Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

Pelthos Therapeutics Inc.

CIK 1919246 PTHS·Biological Products · All EDGAR filings ↗

Progression

  1. Finance chief departure 8-K
  2. Auditor change 8-K +41d
  3. Restatement 8-K +84d
Refine

Restatement SEC item code

Pelthos Therapeutics Inc. said previously issued financial statements should no longer be relied upon

Item 4.02(a) — management or the board reached the conclusion

Evidence
Item code
4.02
Item title
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Limb
a
Limb basis
explicit item reference
Limb label
Item 4.02(a) — management or the board reached the conclusion
Severity
normal
Source
SEC 8-K item code
Why
The company told investors that previously issued financial statements should no longer be relied upon.

Source filing ↗

Auditor change SEC item code

Pelthos Therapeutics Inc. dismissed CBIZ and engaged Grant Thornton

The company dismissed the auditor. CBIZ → Grant Thornton No disagreements disclosed.

Evidence
Direction
dismissed
Direction label
The company dismissed the auditor
Disagreements disclosed
No
Item code
4.01
Item title
Changes in Registrant's Certifying Accountant
Predecessor auditor
CBIZ
Predecessor tier
national
Severity
normal
Source
SEC 8-K item code
Successor auditor
Grant Thornton
Successor tier
national
Why
The company's independent registered accounting firm changed.

Source filing ↗

Finance chief departure elevated Filing comparison

Pelthos Therapeutics Inc.'s Chief Financial Officer departed, replaced on an interim basis

Evidence
Interim only
Yes
Item code
5.02
Item title
Departure of Directors or Certain Officers
Role
Chief Financial Officer
Severity
elevated
Source
SEC 8-K item code
Successor named
No
Why
The company's chief financial or accounting officer departed, disclosed under 8-K Item 5.02.

Source filing ↗

Finance chief departure Filing comparison

Pelthos Therapeutics Inc.'s Chief Financial Officer departed and a successor was named

Evidence
Interim only
No
Item code
5.02
Item title
Departure of Directors or Certain Officers
Role
Chief Financial Officer
Severity
normal
Source
SEC 8-K item code
Successor named
Yes
Why
The company's chief financial or accounting officer departed, disclosed under 8-K Item 5.02.

Source filing ↗